If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
association |
not provided |
total |
191
|
243
|
1024
|
31
|
21
|
1
|
8
|
1516
|
Gene and significance breakdown #
Total genes and gene combinations: 38
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
association |
not provided |
total |
MSH6
|
129
|
119
|
600
|
3
|
1
|
0 |
0 |
849
|
MSH3
|
7
|
98
|
329
|
0 |
0 |
0 |
0 |
434
|
DHFR, MSH3
|
0 |
15
|
48
|
1
|
1
|
0 |
0 |
65
|
PMS2
|
14
|
3
|
8
|
8
|
16
|
0 |
0 |
49
|
MSH2
|
7
|
1
|
4
|
5
|
1
|
0 |
0 |
18
|
MLH1
|
8
|
0 |
2
|
2
|
1
|
0 |
0 |
13
|
LOC126807437, MSH3
|
0 |
2
|
7
|
0 |
0 |
0 |
0 |
9
|
BRCA2
|
4
|
0 |
3
|
1
|
0 |
0 |
0 |
8
|
BRCA1
|
5
|
0 |
1
|
1
|
0 |
0 |
0 |
7
|
MLH3
|
0 |
1
|
4
|
1
|
0 |
0 |
0 |
6
|
PALB2
|
0 |
0 |
2
|
4
|
0 |
0 |
0 |
6
|
ATM
|
3
|
0 |
2
|
0 |
0 |
0 |
0 |
5
|
CDH1
|
2
|
0 |
2
|
0 |
0 |
0 |
0 |
4
|
CHEK2
|
2
|
0 |
2
|
0 |
0 |
0 |
0 |
4
|
LOC129933707, MSH6
|
0 |
0 |
4
|
0 |
0 |
0 |
0 |
4
|
PTEN
|
4
|
0 |
0 |
0 |
0 |
0 |
0 |
4
|
EGFR
|
0 |
0 |
0 |
0 |
0 |
0 |
3
|
3
|
POLD1
|
0 |
0 |
1
|
2
|
0 |
0 |
0 |
3
|
APC
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
2
|
ATM, C11orf65
|
0 |
0 |
1
|
1
|
0 |
0 |
0 |
2
|
FGFR2
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
KRAS
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
2
|
PIK3CA
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
2
|
ABCA3, BRICD5, CASKIN1, DNASE1L2, E4F1, ECI1, LOC112340386, LOC112340387, LOC129390754, LOC130058211, LOC130058212, LOC130058213, LOC130058214, LOC130058215, LOC130058216, LOC130058217, LOC130058218, LOC130058219, LOC130058220, LOC130058221, LOC130058222, LOC130058223, LOC130058224, LOC130058225, LOC130058226, LOC130058227, LOC130058228, MIR1225, MIR3180-5, MIR3677, MIR3677HG, MIR4516, MIR4717, MIR6511B1, MIR940, MLST8, PGP, PKD1, RAB26, RNPS1, SNHG19, SNORD60, TRAF7, TSC2
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
ALK, ARHGEF33, ATL2, BIRC6, CAPN13, CAPN14, CDC42EP3, CDKL4, CEBPZ, CRIM1, CYP1B1, DHX57, DPY30, EHD3, EIF2AK2, EML4, FAM98A, FEZ2, GALM, GALNT14, GEMIN6, GPATCH11, HEATR5B, HNRNPLL, LBH, LCLAT1, LINC02898, LTBP1, MAP4K3, MEMO1, MORN2, NDUFAF7, NLRC4, PKDCC, PRKD3, QPCT, RASGRP3, RMDN2, SLC30A6, SLC8A1, SOS1, SOS1-IT1, SPAST, SRD5A2, SRSF7, STRN, SULT6B1, THUMPD2, TMEM178A, TTC27, VIT, XDH, YIPF4, YPEL5
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
AREL1, MLH3
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
ARID1A
|
0 |
0 |
0 |
0 |
0 |
1
|
0 |
1
|
BARD1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
BRAF
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
1
|
CDH1, TANGO6
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
ERBB2
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
1
|
FGFR3, LOC116158483, LOC129992009, LOC129992010, LOC129992011, LOC129992012, TACC3
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
LOC129390903, RAD51C
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
MUTYH
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
POLE
|
0 |
0 |
0 |
0 |
1
|
0 |
0 |
1
|
RAD51C
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
STK11
|
0 |
0 |
0 |
1
|
0 |
0 |
0 |
1
|
TP53
|
0 |
0 |
0 |
1
|
0 |
0 |
0 |
1
|
Submitter and significance breakdown #
Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
association |
not provided |
total |
Baylor Genetics
|
108
|
230
|
975
|
1
|
0 |
0 |
0 |
1314
|
Department of Pathology and Laboratory Medicine, Sinai Health System
|
46
|
7
|
38
|
27
|
20
|
0 |
0 |
138
|
CZECANCA consortium
|
31
|
1
|
0 |
0 |
0 |
0 |
0 |
32
|
OMIM
|
8
|
0 |
0 |
0 |
0 |
0 |
0 |
8
|
Laboratory of Translational Genomics, National Cancer Institute
|
0 |
0 |
0 |
0 |
0 |
0 |
8
|
8
|
Mendelics
|
6
|
0 |
1
|
0 |
0 |
0 |
0 |
7
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
|
1
|
0 |
4
|
1
|
0 |
0 |
0 |
6
|
Neuberg Centre For Genomic Medicine, NCGM
|
0 |
1
|
5
|
0 |
0 |
0 |
0 |
6
|
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
|
1
|
0 |
5
|
0 |
0 |
0 |
0 |
6
|
Centogene AG - the Rare Disease Company
|
1
|
2
|
0 |
0 |
0 |
0 |
0 |
3
|
Institute of Human Genetics, University of Leipzig Medical Center
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
3
|
Precision Medicine Oncology, Rutgers Cancer Institute of New Jersey
|
0 |
2
|
1
|
0 |
0 |
0 |
0 |
3
|
CSER _CC_NCGL, University of Washington
|
1
|
0 |
0 |
1
|
0 |
0 |
0 |
2
|
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
Western Connecticut Health Network, Rudy L. Ruggles Biomedical Research Institute
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
MGZ Medical Genetics Center
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
|
0 |
0 |
0 |
0 |
1
|
0 |
0 |
1
|
Department of Pathology, Brigham and Women's Hospital
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
ACT Genomics,
|
0 |
0 |
0 |
1
|
0 |
0 |
0 |
1
|
Medical Genetics Laboratory, Umraniye Training and Research Hospital, University of Health Sciences
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Human Genetics Bochum, Ruhr University Bochum
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
KCCC/NGS Laboratory, Kuwait Cancer Control Center
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Solve-RD Consortium
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Martignetti Lab, Icahn School of Medicine at Mount Sinai
|
0 |
0 |
0 |
0 |
0 |
1
|
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.